Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04412187
NA

Inflammatory faCtors AfteR acUte Ischemic Stroke

Sponsor: Martin Dichgans

View on ClinicalTrials.gov

Summary

ICARUS is an interventional single-centre hospital-based cohort study in patients admitted to the stroke unit with an acute ischemic stroke. The aims of the study are to i) define the characteristics and determinants of microglial activation after human stroke, and ii) assess the correlation of microglial activation with circulating inflammatory markers, structural brain changes on neuroimaging, and neurological outcomes. ICARUS involves serial TSPO-PET imaging along with serial MRI, immune cell profiling in blood, and both clinical and laboratory assessments in 36 patients with acute ischemic stroke caused by a cortical (N=18) or strictly subcortical (N=18) infarct. In a substudy, the investigators will include 10 independently recruited patients with acute ischemic stroke to assess MRI arterial spin labelling (ASL) sequences as a marker for perfusion measurement of the TSPO tracer.

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2020-07-01

Completion Date

2027-12-31

Last Updated

2025-04-04

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

[18F]-GE-180 PET

serial \[18F\]-GE-180 PET imaging to assess microglia activation

DIAGNOSTIC_TEST

3T MRI

serial MR imaging (i) to determine infarct characteristics, (ii) to identify gray and white matter structures connected to the infarct, (iii) to detect incident lesions, and (iv) to quantify longitudinal changes e.g. of cortical thickness

DIAGNOSTIC_TEST

immune cell profiling in blood

Cell-specific cytokine profiles, markers of activation, terminal differentiation as well as cytotoxicity will be assesses using flow cytometry.

Locations (2)

Insitute for Stroke and Dementia Research

Munich, Germany, Germany

Department of Nuclear Medicine

Munich, Germany